AGMB AgomAb Therapeutics NV - ADRs representing one common share.
AGMB Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
AGMB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
AGMB Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 4 33.3%
- Buy 7 58.3%
- Hold 1 8.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
5 analysts · 2026-08-17My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 34 filers · $328.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 9 | 7 | 4 | 6 | — |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| EQT Fund Management S.a r.l. | $66,743,056 | 5,141,992 | 20.35% | Shares |
| Sanofi | $36,124,586 | 2,783,096 | 11.01% | Shares |
| Redmile Group, LLC | $35,486,359 | 2,733,926 | 10.82% | Shares |
| Cormorant Asset Management, LP | $32,000,217 | 2,465,348 | 9.76% | Shares |
| TCG Crossover Management, LLC | $26,650,964 | 2,053,233 | 8.13% | Shares |
| FEDERATED HERMES, INC. | $21,001,640 | 1,618,000 | 6.40% | Shares |
| Nantahala Capital Management, LLC | $20,355,080 | 1,568,188 | 6.21% | Shares |
| Casdin Capital, LLC | $20,119,000 | 1,550,000 | 6.13% | Shares |
| ANDERA PARTNERS | $19,972,352 | 1,538,702 | 6.09% | Shares |
| Aberdeen Group plc | $10,990,101 | 846,695 | 3.35% | Shares |
| FMR LLC | $10,222,178 | 787,533 | 3.12% | Shares |
| PERCEPTIVE ADVISORS LLC | $7,788,000 | 600,000 | 2.37% | Shares |
| SAMSARA BIOCAPITAL, LLC | $7,788,000 | 600,000 | 2.37% | Shares |
| Siren, L.L.C. | $5,338,025 | 411,250 | 1.63% | Shares |
| ORBIMED ADVISORS LLC | $2,501,765 | 192,740 | 0.76% | Shares |
| Pfizer Inc | $1,035,750 | 75,000 | 0.32% | Shares |
| ALPS ADVISORS INC | $648,792 | 49,984 | 0.20% | Shares |
| Bellevue Group AG | $639,239 | 49,248 | 0.19% | Shares |
| SEVEN GRAND MANAGERS, LLC | $617,848 | 47,600 | 0.19% | Shares |
| SECTORAL ASSET MANAGEMENT INC | $564,630 | 43,500 | 0.17% | Shares |
| Burkehill Global Management, LP | $454,300 | 35,000 | 0.14% | Shares |
| Quadrature Capital Ltd | $265,584 | 20,461 | 0.08% | Shares |
| TWO SIGMA INVESTMENTS, LP | $234,575 | 18,072 | 0.07% | Shares |
| GOLDMAN SACHS GROUP INC | $153,164 | 11,800 | 0.05% | Shares |
| XTX Topco Ltd | $133,318 | 10,271 | 0.04% | Shares |
| CITIGROUP INC | $123,258 | 9,496 | 0.04% | Shares |
| GAMMA Investing LLC | $17,445 | 1,344 | 0.01% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $9,787 | 754 | 0.00% | Shares |
| Larson Financial Group LLC | $9,060 | 698 | 0.00% | Shares |
| UBS Group AG | $5,893 | 454 | 0.00% | Shares |
| MORGAN STANLEY | $2,596 | 200 | 0.00% | Shares |
| HRT FINANCIAL LP | $221 | 17,075 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $26 | 2 | 0.00% | Shares |
| SBI Securities Co., Ltd. | $26 | 2 | 0.00% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| LSP 7 Cooperatieve U.A., LSP 7 Management B.V. | Feb. 17, 2026 | 10.60% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.